|
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet (clinical drug)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet
Id377460002
StatusDefined
Has manufactured dose formOral tablet
Has unit of presentationTablet
Has BoSSHydralazine hydrochloride
Has precise active ingredientHydralazine hydrochloride
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg
Has BoSSreserpine
Has precise active ingredientreserpine
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmcg
Has BoSShydrochloorthiazide
Has precise active ingredienthydrochloorthiazide
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg